Over recent decades, obesity has grown into a global health crisis where 38% of U.S. adults and more than 17% of children are currently obese. A 2015 study revealed statistics that are even more alarming: more than 600 million adults and 100 million children worldwide are considered obese.
Effective January 4, 2019, the Michigan Automated Prescription System (MAPS) for the reporting of controlled substances made gabapentin a Schedule V controlled substance. Pharmacies have 7 days to comply, which is Friday, January 11.
Effective January 1, 2019, the Tennessee Prescription Monitoring Program (TN PMP) requires reporting of the Treatment Type and ICD-10 Diagnosis Code.
Pharmacists practicing at the top of their licenses is something Ed Vess, R.Ph., has long advocated. QS/1’s senior manager of pharmacy professional affairs wants pharmacists to use their education to provide clinical patient care and claim their place as reimbursed members of the healthcare team.
It may seem like an extra burden to join and spend money on yet another professional organization, but the benefits of doing so are immense.
As a 36-year QS/1 customer, the Heart of Texas Community Health Center, known locally as Waco Family Health Center, has relied on pharmacy solutions that fit its unique setup and can be customized as the need arises.
When you purchase our pharmacy software solutions, you become part of our community. As a team, we work together to guarantee you get the most out of your software while providing your pharmacy with the resources needed to be successful, ensuring your voice is heard, and continuously improving our services to aid you.
Effective December 4, 2018, the Minnesota Prescription Monitoring Program (MN PMP) moved controlled substance reporting to the Appriss® PMP Clearinghouse.
Of all the caregivers a patient encounters, community pharmacists are often the most accessible. There is increasing focus on how their availability and clinical know-how can be used to create better outcomes for patients, particularly the high-risk and chronically ill.
Once again, QS/1 is leading the way to help you make the transition from the current version of the National Council for Prescription Drug Programs (NCPDP) SCRIPT standard to the new one as smooth as possible. Pharmacies and prescribers that transmit electronic prescriptions have a little more than a year to convert to the new version. Currently, pharmacies and prescribers that wish to prescribe electronically must transmit those e-prescriptions using the SCRIPT Standard version 10.6. On January 1, 2020, transmissions must be made using the New SCRIPT Standard version 2017071.
QS/1 is honoring pharmacists at the 2018 National Community Pharmacists Association (NCPA) Annual Convention by donating to charities in the name of three pharmacists.
A new member of the J M Smith corporate family, Mevesi is now part of the Integra product suite. Already integrated with QS/1’s NRx and Integra’s PrimeCare, its platforms include Business Intelligence, Pharmacy Edge, and Transitions of Care geared to the pharmacy-hospital relationship.